Comparative Effects of Phosphoenolpyruvate, a Glycolytic Intermediate, as an Organ Preservation Agent with Glucose and N-Acetylcysteine against Organ Damage during Cold Storage of Mouse Liver and Kidney.

Phosphoenolpyruvate administration protects ischemia-reperfusion injury in isolated rabbit lungs. J Anesth (2015) 0.75

Extended preservation of human liver grafts with UW solution. JAMA (1989) 3.99

Multicenter analysis of kidney preservation. Transplantation (2007) 2.39

Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. Transplant Proc (2008) 1.53

Role of reactive oxygen species in mediating hepatic ischemia-reperfusion injury and its therapeutic applications in liver transplantation. Transplant Proc (2007) 1.15

Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling. Transplantation (2009) 1.04

Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review. Liver Transpl (2007) 1.01

Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res (2009) 1.00

Transport of phosphoenolpyruvate through the erythrocyte membrane. Biochem J (1978) 0.85

Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int (1999) 0.84

Safety and efficacy of living donor liver preservation with HTK solution. Transplant Proc (2005) 0.83

Phosphoenolpyruvic acid, an intermediary metabolite of glycolysis, as a potential cytoprotectant and anti-oxidant in HeLa cells. Biol Pharm Bull (2012) 0.82

Phosphoenolpyruvate/adenosine triphosphate enhances post-ischemic survival of skeletal muscle. J Reconstr Microsurg (1995) 0.81

Phosphoenolpyruvate prevents the decline in hepatic ATP and energy charge after ischemia and reperfusion injury in rats. J Surg Res (1997) 0.81

Phosphoenolpyruvate, a glycolytic intermediate, as a cytoprotectant and antioxidant in ex-vivo cold-preserved mouse liver: a potential application for organ preservation. J Pharm Pharmacol (2012) 0.81

Myocardial energy restoration of ischemic damage by administration of phosphoenolpyruvate during reperfusion. A study in a paracorporeal rat heart model. Eur Surg Res (1983) 0.80

The exacerbating roles of CCAAT/enhancer-binding protein homologous protein (CHOP) in the development of bleomycin-induced pulmonary fibrosis and the preventive effects of tauroursodeoxycholic acid (TUDCA) against pulmonary fibrosis in mice. Pharmacol Res (2015) 0.78

Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice. Pharmacol Res (2014) 0.76

In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-Pick Type C disease. Mol Genet Metab (2016) 0.76

Influence of Npc1 genotype on the toxicity of hydroxypropyl-β-cyclodextrin, a potentially therapeutic agent, in Niemann-Pick Type C disease models. Mol Genet Metab Rep (2014) 0.75

Corrigendum to "In vitro evaluation of 2-hydroxyalkylated β-cyclodextrins as potential therapeutic agents for Niemann-pick type C disease" [Mol. Genet. Metab. (2016) 214-219]. Mol Genet Metab (2016) 0.75